Epithelial cell-derived secreted and transmembrane 1a signals to activated neutrophils during pneumococcal pneumonia

American Journal of Respiratory Cell and Molecular Biology

Volumn 55, Issue 3, 2016, Pages 407-418

  Kamata, Hirofumi ^a   Yamamoto, Kazuko ^a,b   Wasserman, Gregory A ^a   Zabinski, Mary C ^a   Yuen, Constance K ^c   Lung, Wing Yi ^c   Gower, Adam C ^a   Belkina, Anna C ^a   Ramirez, Maria I ^a   Deng, Jane C ^c   Quinton, Lee J ^a   Jones, Matthew R ^a   Mizgerd, Joseph P ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NAGASAKI UNIVERSITY   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CXCL2; Lung epithelium; Neutrophil activation; Pneumococcal pneumonia; Type I IFNs

Indexed keywords

CD11B ANTIGEN; CXCL2 CHEMOKINE; INTERFERON; MEMBRANE PROTEIN; SECTM1A PROTEIN; SECTM1B PROTEIN; STAT1 PROTEIN; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; RECOMBINANT PROTEIN; SECTM1A PROTEIN, MOUSE;

AIRWAY EPITHELIAL CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL POPULATION; CELL SELECTION; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC TRANSCRIPTION; MOUSE; NEUTROPHIL; NONHUMAN; POSITIVE FEEDBACK; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIA; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; ELECTRIC CONDUCTIVITY; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; LEUKOCYTE ACTIVATION; LUNG; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; CHEMOKINE CXCL2; ELECTRIC CONDUCTIVITY; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; INTERFERON TYPE I; LUNG; MEMBRANE PROTEINS; MICE, INBRED C57BL; MYELOID CELLS; NEUTROPHIL ACTIVATION; NEUTROPHILS; PNEUMONIA, PNEUMOCOCCAL; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIAE;

EID: 84988925348     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2015-0261OC     Document Type: Article

References (50)

1. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2163-2196.
2. Bauer TT, Ewig S, Rodloff AC, Müller EE. Acute respiratory distress syndrome and pneumonia: a comprehensive review of clinical data. Clin Infect Dis 2006;43:748-756.
3. Armstrong GL, Conn LA, Pinner RW. Trends in infectious disease mortality in the United States during the 20th century. JAMA 1999; 281:61-66.
4. van der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 2009;374:1543-1556.
5. Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, Reed C, Grijalva CG, Anderson EJ, Courtney DM, et al.; CDC EPIC Study Team. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med 2015;373:415-427.
6. Cleaver JO, You D, Michaud DR, Pruneda FA, Juarez MM, Zhang J, Weill PM, Adachi R, Gong L, Moghaddam SJ, et al. Lung epithelial cells are essential effectors of inducible resistance to pneumonia. Mucosal Immunol 2014;7:78-88.
7. Parker D, Prince A. Innate immunity in the respiratory epithelium. Am J Respir Cell Mol Biol 2011;45:189-201.
8. Quinton LJ, Jones MR, Simms BT, Kogan MS, Robson BE, Skerrett SJ, Mizgerd JP. Functions and regulation of NF-kB RelA during pneumococcal pneumonia. J Immunol 2007;178:1896-1903.
9. Quinton LJ, Jones MR, Robson BE, Simms BT, Whitsett JA, Mizgerd JP. Alveolar epithelial STAT3, IL-6 family cytokines, and host defense during Escherichia coli pneumonia. Am J Respir Cell Mol Biol 2008;38: 699-706.
10. Yamamoto K, Ferrari JD, Cao Y, Ramirez MI, Jones MR, Quinton LJ, Mizgerd JP. Type I alveolar epithelial cells mount innate immune responses during pneumococcal pneumonia. J Immunol 2012;189: 2450-2459.
11. Yamamoto K, Ahyi AN, Pepper-Cunningham ZA, Ferrari JD, Wilson AA, Jones MR, Quinton LJ, Mizgerd JP. Roles of lung epithelium in neutrophil recruitment during pneumococcal pneumonia. Am J Respir Cell Mol Biol 2014;50:253-262.
12. Slentz-Kesler KA, Hale LP, Kaufman RE. Identification and characterization of K12 (SECTM1), a novel human gene that encodes a Golgi-associated protein with transmembrane and secreted isoforms. Genomics 1998;47:327-340.
13. Lyman SD, Escobar S, Rousseau AM, Armstrong A, Fanslow WC. Identification of CD7 as a cognate of the human K12 (SECTM1) protein. J Biol Chem 2000;275:3431-3437.
14. Howie D, Garcia Rueda H, Brown MH, Waldmann H. Secreted and transmembrane 1A is a novel co-stimulatory ligand. PLoS One 2013; 8:e73610.
15. Wang T, Huang C, Lopez-Coral A, Slentz-Kesler KA, Xiao M, Wherry EJ, Kaufman RE. K12/SECTM1, an interferon-g regulated molecule, synergizes with CD28 to costimulate human T cell proliferation. J Leukoc Biol 2012;91:449-459.
16. Wang T, Ge Y, Xiao M, Lopez-Coral A, Li L, Roesch A, Huang C, Alexander P, Vogt T, Xu X, et al. SECTM1 produced by tumor cells attracts human monocytes via CD7-mediated activation of the PI3K pathway. J Invest Dermatol 2014;134:1108-1118.
17. Bade-Doding C, Gottmann W, Baigger A, Farren M, Lee KP, Blasczyk R, Huyton T. Autocrine GM-CSF transcription in the leukemic progenitor cell line KG1a is mediated by the transcription factor ETS1 and is negatively regulated through SECTM1 mediated ligation of CD7. Biochim Biophys Acta 2014;1840:1004-1013.
18. Lo B, Hansen S, Evans K, Heath JK, Wright JR. Alveolar epithelial type II cells induce T cell tolerance to specific antigen. J Immunol 2008; 180:881-888.
19. Shahangian A, Chow EK, Tian X, Kang JR, Ghaffari A, Liu SY, Belperio JA, Cheng G, Deng JC. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest 2009; 119:1910-1920.
20. Francis KP, Yu J, Bellinger-Kawahara C, Joh D, Hawkinson MJ, Xiao G, Purchio TF, Caparon MG, Lipsitch M, Contag PR. Visualizing pneumococcal infections in the lungs of live mice using bioluminescent Streptococcus pneumoniae transformed with a novel gram-positive lux transposon. Infect Immun 2001;69:3350-3358.
21. Jones MR, Quinton LJ, Simms BT, Lupa MM, Kogan MS, Mizgerd JP. Roles of interleukin-6 in activation of STAT proteins and recruitment of neutrophils during Escherichia coli pneumonia. J Infect Dis 2006; 193:360-369.
22. Briles DE, Hollingshead SK, Paton JC, Ades EW, Novak L, van Ginkel FW, Benjamin WH Jr. Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae. J Infect Dis 2003;188:339-348.
23. Lefort CT, Rossaint J, Moser M, Petrich BG, Zarbock A, Monkley SJ, Critchley DR, Ginsberg MH, Fässler R, Ley K. Distinct roles for talin-1 and kindlin-3 in LFA-1 extension and affinity regulation. Blood 2012; 119:4275-4282.
24. Sauer KA, Scholtes P, Karwot R, Finotto S. Isolation of CD41 T cells from murine lungs: a method to analyze ongoing immune responses in the lung. Nat Protoc 2006;1:2870-2875.
25. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005;102:15545-15550.
26. Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009;4:44-57.
27. Tamura T, Yanai H, Savitsky D, Taniguchi T. The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol 2008;26:535-584.
28. Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011;34: 637-650.
29. Decker T, Müller M, Stockinger S. The yin and yang of type I interferon activity in bacterial infection. Nat Rev Immunol 2005;5:675-687.
30. Ivashkiv LB, Donlin LT. Regulation of type I interferon responses. Nat Rev Immunol 2014;14:36-49.
31. Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S, Crowley D, Bronson RT, Jacks T. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005;121:823-835.
32. Rock JR, Gao X, Xue Y, Randell SH, Kong YY, Hogan BL. Notchdependent differentiation of adult airway basal stem cells. Cell Stem Cell 2011;8:639-648.
33. Kotton DN, Morrisey EE. Lung regeneration: mechanisms, applications and emerging stem cell populations. Nat Med 2014;20:822-832.
34. Lee YS, Choi JW, Hwang I, Lee JW, Lee JH, Kim AY, Huh JY, Koh YJ, Koh GY, Son HJ, et al. Adipocytokine orosomucoid integrates inflammatory and metabolic signals to preserve energy homeostasis by resolving immoderate inflammation. J Biol Chem 2010;285: 22174-22185.
35. Hochepied T, Berger FG, Baumann H, Libert C. Alpha1-acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties. Cytokine Growth Factor Rev 2003;14:25-34.
36. Quinton LJ, Blahna MT, Jones MR, Allen E, Ferrari JD, Hilliard KL, Zhang X, Sabharwal V, Algül H, Akira S, et al. Hepatocyte-specific mutation of both NF-kB RelA and STAT3 abrogates the acute phase response in mice. J Clin Invest 2012;122:1758-1763.
37. Mizgerd JP. Acute lower respiratory tract infection. N Engl J Med 2008; 358:716-727.
38. Carrero JA. Confounding roles for type I interferons during bacterial and viral pathogenesis. Int Immunol 2013;25:663-669.
39. Trinchieri G. Type I interferon: friend or foe? J Exp Med 2010;207: 2053-2063.
40. LeMessurier KS, Häcker H, Chi L, Tuomanen E, Redecke V. Type I interferon protects against pneumococcal invasive disease by inhibiting bacterial transmigration across the lung. PLoS Pathog 2013;9:e1003727.
41. Damjanovic D, Khera A, Medina MF, Ennis J, Turner JD, Gauldie J, Xing Z. Type 1 interferon gene transfer enhances host defense against pulmonary Streptococcus pneumoniae infection via activating innate leukocytes. Mol Ther Methods Clin Dev 2014;1:5.
42. Yamada M, Gomez JC, Chugh PE, Lowell CA, Dinauer MC, Dittmer DP, Doerschuk CM. Interferon-g production by neutrophils during bacterial pneumonia in mice. Am J Respir Crit Care Med 2011;183: 1391-1401.
43. Becher B, Schlitzer A, Chen J, Mair F, Sumatoh HR, Teng KW, Low D, Ruedl C, Riccardi-Castagnoli P, Poidinger M, et al. High-dimensional analysis of the murine myeloid cell system. Nat Immunol 2014;15: 1181-1189.
44. Yong KL, Rowles PM, Patterson KG, Linch DC. Granulocytemacrophage colony-stimulating factor induces neutrophil adhesion to pulmonary vascular endothelium in vivo: role of b2 integrins. Blood 1992;80:1565-1575.
45. Satake S, Hirai H, Hayashi Y, Shime N, Tamura A, Yao H, Yoshioka S, Miura Y, Inaba T, Fujita N, et al. C/EBPb is involved in the amplification of early granulocyte precursors during candidemiainduced ?emergency? granulopoiesis. J Immunol 2012;189: 4546-4555.
46. Lee PY, Wang JX, Parisini E, Dascher CC, Nigrovic PA. Ly6 family proteins in neutrophil biology. J Leukoc Biol 2013;94:585-594.
47. Miller MD, Krangel MS. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol 1992;12:17-46.
48. Greenberger MJ, Strieter RM, Kunkel SL, Danforth JM, Laichalk LL, McGillicuddy DC, Standiford TJ. Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia. J Infect Dis 1996; 173:159-165.
49. Standiford TJ, Kunkel SL, Greenberger MJ, Laichalk LL, Strieter RM. Expression and regulation of chemokines in bacterial pneumonia. J Leukoc Biol 1996;59:24-28.
50. Brandes M, Klauschen F, Kuchen S, Germain RN. A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection. Cell 2013;154:197-212.